Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide<scp>1B</scp>clinical probe than rosuvastatin

Thomayant Prueksaritanont, Xiaoyan Chu, Raymond Evers, +11

British Journal of Clinical Pharmacology

Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis

Bernard Rocheleau, Chantal Éthier, Robert Houle, +2

American Journal of Physiology-Gastrointestinal and Liver Physiology

Full LpvsGastroenterologyPathologySurgeryLiver Tissue Homeostasis +18

Evaluation of hepatocyte injury following partial ligation of the left portal vein

Marc Bilodeau, Marie‐Christine Aubry, Robert Houle, +2

Journal of Hepatology

HepatologyLiver PhysiologyHepatitisHepatology InflammationHepatotoxicity +8

The identification of potent, selective, and bioavailable cathepsin S inhibitors

Jacques Yves Gauthier, W. Cameron Black, Isabelle Courchesne, +13

Bioorganic & Medicinal Chemistry Letters

Medicinal ChemistryPharmaceutical ScienceBiochemistryNatural SciencesMedicine +6

Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases

Michel Gallant, Christian Beaulieu, Carl Berthelette, +32

Bioorganic & Medicinal Chemistry Letters

Respiratory DiseasesPharmacologyMechanism Of ActionSelective Crth2 AntagonistPharmacotherapy +3

Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes

Robert Houle, Jean-François Lévesque, K. Sandy Pang, +2

Drug Metabolism and Disposition

Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulation of proapoptotic Bid protein

Chantal Éthier, Valérie‐Ann Raymond, Lina Musallam, +2

American Journal of Physiology-Gastrointestinal and Liver Physiology

ApoptosisImmunologyPathologyCell DeathCell Proliferation +18

<i>In Vitro</i> Evaluation of the Drug Interaction Potential of Doravirine

Kelly Bleasby, Kerry L. Fillgrove, Robert Houle, +6

Antimicrobial Agents and Chemotherapy

Azaindoles as potent CRTH2 receptor antagonists

Daniel Simard, Yves Leblanc, Carl Berthelette, +13

Bioorganic & Medicinal Chemistry Letters

MedicineMechanism Of ActionPharmacological AgentPharmacotherapyPharmacology +1

Raltegravir Has a Low Propensity To Cause Clinical Drug Interactions through Inhibition of Major Drug Transporters: an <i>In Vitro</i> Evaluation

Matthew L. Rizk, Robert Houle, Grace Chan, +3

Antimicrobial Agents and Chemotherapy